Insider · CIK 0002042509
Carlos Luis Lopez
Files at NAGE (Niagen Bioscience, Inc.). First filing Mar 10, 2025, latest Mar 10, 2025.
Carlos Luis Lopez files SEC Form 4 as officer at NAGE (Niagen Bioscience, Inc.). Since Mar 10, 2025, Carlos Luis Lopez has reported 1 open-market buy worth $2,146 and 0 open-market sells worth $0, the latest filed on Mar 10, 2025.
A track record needs three past buys with six months of prices behind them; Carlos Luis Lopez has 0, so none is measured yet.
The newest scored trade: bought $2,146 of NAGE on Mar 7, 2025, filed Mar 10, 2025, scored 18 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NAGE: Niagen Bioscience, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | NAGEbuy Niagen Bioscience, Inc. | $2,146 273 shares | +14% | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | NAGE Niagen Bioscience, Inc. | AGrant or award Common Stock | +2,314 | $2.71 | $6,271 | 4,565 | Jul 8, 2026 |
| Feb 19, 2026 | NAGE Niagen Bioscience, Inc. | AGrant or award Employee Stock Options (right to buy)derivative | +41,420 | $0.00 | $0 | 41,420 | Feb 24, 2026 |
| Mar 7, 2025 | NAGE Niagen Bioscience, Inc. | POpen-market purchase Common Stock | +273 | $7.86 | $2,146 | 2,251 | Mar 10, 2025 |
| Feb 12, 2025 | NAGE Niagen Bioscience, Inc. | AGrant or award Employee Stock Options (right to buy)derivative | +19,691 | $0.00 | $0 | 19,691 | Feb 14, 2025 |
Questions about Carlos Luis Lopez
Answered from the filings on this page, as of the latest one.
Is Carlos Luis Lopez buying or selling?
Not in the last 12 months. Carlos Luis Lopez's latest open-market trade on SEC Form 4 was bought $2,146 of NAGE on Mar 7, 2025.
How did Carlos Luis Lopez's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Carlos Luis Lopez has 0.
Where does Carlos Luis Lopez file Form 4?
Carlos Luis Lopez has filed Form 4 at NAGE (Niagen Bioscience, Inc.) as SVP, General Counsel. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.